Adaptive Biotechnologies Corp (ADPT) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-02-05

Key Insights

Adaptive Biotechnologies reported its Q4 2025 and full-year 2025 financial results, providing investors with an update on the company's recent performance.
The company's press release indicates that key financial metrics, such as revenue and profitability, will be an important focus for investors to assess the company's progress.
Investors should pay close attention to any commentary or guidance provided by the company regarding its future outlook and growth prospects.

Want the newest filings?

This analysis covers the filing from 2026-02-05. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-12

Adaptive Biotechnologies reported its Q4 2025 and full-year 2025 financial results, indicating strong revenue growth and improving profitability.
The company provided an investor presentation with additional details on its product pipeline, commercial strategy, and long-term growth initiatives.
No material agreements, leadership changes, or other significant events were disclosed in this 8-K filing.

Filed: 2025-12-30

Adaptive Biotechnologies' majority-owned subsidiary Digital Biotechnologies raised up to $15 million in a Series A financing round, demonstrating the company's ability to attract external capital to fund its growth.
The filing indicates that Adaptive Biotechnologies expects to retain nearly 50% ownership in Digital Biotechnologies after the Series A round, suggesting the parent company will continue to have a significant stake and influence in the subsidiary's operations.
The company provided forward-looking statements about the completion of the financing and its expected ownership interest, indicating transparency and setting investor expectations around this key corporate development.

Other reports for Adaptive Biotechnologies Corp

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.